Chewed Versus Integral Pill of Ticagrelor

Inclusion Criteria: • All patients presenting to the cardiac catheterization lab for percutaneous coronary intervention. Exclusion Criteria: * Age \<18 years or Age \>89 years * Known coagulopathy, bleeding diathesis, or active bleeding * History of recent gastrointestinal or genitourinary bleed within 2 months * Known chronic therapy with clopidogrel, prasugrel, or ticagrelor * Major surgery within last 6 weeks * History of intracranial bleed or intracranial neoplasm * Suspected aortic dissection * Severe hemodynamic instability, cardiogenic shock * Life expectancy \<1 year * Known severe liver or renal disease * Known HIV treatment * Any use of Glycoprotein inhibitors (GP IIb-IIIa) 48-hours before the procedure or any use during the procedure * Any use of Cangrelor during or after the procedure * Hemoglobin \<10 g/dL, platelet (PLT) \<100x10\^9/L * Pregnancy * Known allergy to study medication